SCNI logo

SCNI
Scinai Immunotherapeutics Ltd.

5,788
Mkt Cap
$2.24M
Volume
3,711.00
52W High
$6.18
52W Low
$0.4548
PE Ratio
-0.06
SCNI Fundamentals
Price
$0.6449
Prev Close
$0.71
Open
$0.6598
50D MA
$0.6772
Beta
0.87
Avg. Volume
9.81M
EPS (Annual)
-$3.59
P/B
0.90
Rev/Employee
$29,364.44
$7.75
Loading...
Loading...

About

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
45

Frequently Asked Questions

What is Market Cap of Scinai Immunotherapeutics Ltd - ADR?
What is the 52-week high for Scinai Immunotherapeutics Ltd - ADR?
What is the 52-week low for Scinai Immunotherapeutics Ltd - ADR?
What is Scinai Immunotherapeutics Ltd - ADR stock price today?
What was Scinai Immunotherapeutics Ltd - ADR stock price yesterday?
What is the PE ratio of Scinai Immunotherapeutics Ltd - ADR?
What is the Price-to-Book ratio of Scinai Immunotherapeutics Ltd - ADR?
What is the 50-day moving average of Scinai Immunotherapeutics Ltd - ADR?
How many employees does Scinai Immunotherapeutics Ltd - ADR have?

Latest SCNI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.